Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Early clinical data suggests GI side effects are common but manageable
We observed that exendin-asp3 remained bound with highest avidity and exendin-phe1, the least (Fig
TB-500 extends recovery systemically throughout the entire body
Opportunity Regulatory Approvals and Expanding Applications There is a significant opportunity for Monujaro market in the obesity segment, which remains largely under-treated
US$ 21.42
US$ 20.25
US$ 21.73
US$ 26.19
US$ 28.45
US$ 22.18
US$ 21.60
US$ 28.95
US$ 25.65
US$ 29.40
